Jove
Visualize
Contact Us

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to the letter on "Brazilian guidelines for the management of tuberculosis infection in immune-mediated inflammatory diseases: is retesting in latent tuberculosis screening appropriate and safe?"

Advances in rheumatology (London, England)·2025
Same author

Correction: Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.

Advances in rheumatology (London, England)·2025
Same author

Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases.

Advances in rheumatology (London, England)·2025
Same author

Beneficial Bacteria in the Gut Microbiota May Lead to Improved Metabolic and Immunological Status in Chronic Obstructive Pulmonary Disease.

Medical sciences (Basel, Switzerland)·2024
Same author

Laboratory-based study of drug resistance and genotypic profile of multidrug-resistant tuberculosis isolates in Salvador, Bahia, Brazil.

Revista da Sociedade Brasileira de Medicina Tropical·2022
Same author

Evidence of the association between adherence to treatment and mortality among patients with COPD monitored at a public disease management program in Brazil.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2021
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 13, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Multidrug-resistant tuberculosis.

Antônio Carlos Moreira Lemos1, Eliana Dias Matos

  • 1Hospital Especializado Octavio Mangabeira, Salvador, BA, Brazil. acmlemos1@gmail.com

The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|March 13, 2013
PubMed
Summary
This summary is machine-generated.

Multidrug-resistant tuberculosis (MDR-TB) remains a significant global health challenge, with complex and lengthy treatment regimens. Research is ongoing for new drugs and indications to improve treatment effectiveness and patient outcomes.

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Related Experiment Videos

Last Updated: May 13, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Area of Science:

  • Public Health
  • Infectious Diseases
  • Microbiology

Background:

  • Multidrug-resistant tuberculosis (MDR-TB) is a major global health concern, with an estimated 440,000 new cases annually.
  • Diagnosis of resistance relies on phenotypic or genotypic laboratory tests, with a growing need for rapid genotypic methods.
  • Current MDR-TB treatment is lengthy (18-24 months), costly, complex, and associated with adverse reactions.

Purpose of the Study:

  • To summarize the current landscape of multidrug-resistant tuberculosis (MDR-TB).
  • To outline established and emerging treatment principles and regimens for MDR-TB.
  • To highlight ongoing research for improved MDR-TB therapies.

Main Methods:

  • Review of existing literature on MDR-TB diagnosis and treatment.
  • Analysis of current therapeutic principles and standardized regimens, including drug combinations and adjunct therapies like pulmonary resection.
  • Discussion of ongoing clinical studies involving new and repurposed drugs for TB.

Main Results:

  • MDR-TB treatment requires a combination of at least four drugs, including a fluoroquinolone and an injectable agent.
  • Brazil's standardized regimen includes terizidone, levofloxacin, pyrazinamide, ethambutol, and an aminoglycoside.
  • A recent meta-analysis reported an average MDR-TB cure rate of 69%, with promising results from ongoing drug development.

Conclusions:

  • Effective MDR-TB management necessitates adherence to specific drug combination principles.
  • Pulmonary resection can serve as an important adjunctive treatment for MDR-TB.
  • Future MDR-TB treatment regimens are expected to become more effective due to ongoing research and drug development.